CN Patent

CN114940682A — 芦比替定的晶型及其制备方法和用途

Assigned to Borui Pharmaceutical Suzhou Co ltd · Expires 2022-08-26 · 4y expired

What this patent protects

本发明提供一种式(I)所示化合物的晶型及其制备方法与应用。本发明所述的晶型具备高的口服生物利用度且其引湿性低、稳定性好。本发明所述的晶型的制备方法工艺简单，结晶过程易于控制，重现性好。

USPTO Abstract

本发明提供一种式(I)所示化合物的晶型及其制备方法与应用。本发明所述的晶型具备高的口服生物利用度且其引湿性低、稳定性好。本发明所述的晶型的制备方法工艺简单，结晶过程易于控制，重现性好。

Drugs covered by this patent

Patent Metadata

Patent number
CN114940682A
Jurisdiction
CN
Classification
—
Expires
2022-08-26
Drug substance claim
No
Drug product claim
No
Assignee
Borui Pharmaceutical Suzhou Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.